{
    "2020-05-12": [
        [
            {
                "time": "2023-10-04",
                "original_text": "Wall Street Ends in the Red on Tuesday",
                "features": {
                    "keywords": [
                        "Wall Street",
                        "Red",
                        "Tuesday"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "The Dow Can’t Hang On — and REITs Are Getting Crushed",
                "features": {
                    "keywords": [
                        "Dow",
                        "REITs",
                        "Crushed"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "real estate",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "The Dow Is Hanging On — REITs Are Most Certainly Not",
                "features": {
                    "keywords": [
                        "Dow",
                        "REITs",
                        "Hanging On"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "real estate",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "AbbVie Is a Buy as Allergan Deal Closes - A Look at the Charts",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Allergan",
                        "Buy",
                        "Deal"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "FORM 8.3 - ABBVIE INC - Amendment",
                "features": {
                    "keywords": [
                        "Form 8.3",
                        "ABBVIE",
                        "Amendment"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "AbbVie Stock Has 15% Upside With Merger Done, J.P. Morgan Analyst Says",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Merger",
                        "J.P. Morgan",
                        "Upside"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "Reata (RETA) Q1 Earnings Surpass Estimates, Revenues Miss",
                "features": {
                    "keywords": [
                        "Reata",
                        "Q1",
                        "Earnings",
                        "Estimates",
                        "Revenues"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "AbbVie Gets Favorable Analyst Reviews After Allergan Merger",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Favorable",
                        "Analyst",
                        "Allergan",
                        "Merger"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "AbbVie Inc. Just Beat EPS By 10%: Here's What Analysts Think Will Happen Next",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "EPS",
                        "Beat",
                        "Analysts"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}